Clinical Trials Browser

Phase 2 × Chemoradiotherapy × Thoracic × Clear all

NCT07479628 2026-03-18

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

Phase 2 Not yet recruiting

Thymoma

NCT06810609 2026-01-27

InDuRanS

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07264647 2025-12-04

Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07200154 2025-09-30

Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06448910 2025-09-24

Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC

Phase 2 Active not recruiting

NSCLC

NCT06998719 2025-05-31

ACCESS

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06944470 2025-04-25

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

Phase 2 Not yet recruiting

NSCLC

NCT06768307 2025-01-10

Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Phase 2 Not yet recruiting

SCLC, Extensive Stage

NCT04952597 2024-10-26

Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer

Phase 2 Completed

126 enrolled 19 charts

Limited Stage Small Cell Lung Cancer

NCT05904015 2023-06-15

The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Phase 2 Not yet recruiting

Lung Neoplasms

NCT05481775 2022-11-21

Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Phase 2 Withdrawn

Locally Advanced Non-small Cell Lung Cancer

NCT03663764 2021-12-10

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Phase 2 Unknown

Thymoma

NCT01066234 2021-03-22

Adjuvant CCRT vs CT in Minimal N2 NSCLC

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT03672136 2018-09-14

Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00431613 2015-05-29

Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02215356 2014-08-13

Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00490659 2007-06-25

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung